Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Acebilustat

Generic Name: Acebilustat

Drug Type: Small Molecule

Chemical Formula: C_₂₉H_₂₇N_₃O_₄

CAS Number: 943764-99-6

Unique Ingredient Identifier: J64RI4D29U

Overview

Acebilustat is under investigation in clinical trial NCT01748838 (Phase 1 Study Assessing the Safety and Tolerability of CTX-4430).

Background

Acebilustat is under investigation in clinical trial NCT01748838 (Phase 1 Study Assessing the Safety and Tolerability of CTX-4430).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Trial of Acebilustat for the Treatment of Upper Arm Lymphedema

Phase 2

Active, not recruiting

Posted: 2022/01/24

Sponsor:Stanford University

ID:NCT05203835

COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol

Phase 2

Completed

Posted: 2020/12/10

Sponsor:Stanford University

ID:NCT04662086

COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol

Phase 2

Completed

Posted: 2020/12/10

Sponsor:Stanford University

ID:NCT04662060

EMPIRE CF: A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 in Adult Cystic Fibrosis (CF) Patients

Phase 2

Completed

Posted: 2015/05/14

Sponsor:Celtaxsys, Inc.

ID:NCT02443688

CTX-4430 for the Treatment of Moderate to Severe Facial Acne Vulgaris

Phase 2

Completed

Posted: 2015/03/11

Sponsor:Celtaxsys, Inc.

ID:NCT02385760

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy